EQT to acquire TachoSil biosurgery business from Corza Medical

EQT X agreed to acquire Corza Biosurgery, comprising the TachoSil hemostat and sealant patch business, from Corza Medical. The business employs approximately 400 people and manufactures at a facility in Linz, Austria.

“EQT is pleased to announce that EQT X has agreed to acquire Corza Biosurgery from Corza Medical, comprising TachoSil, a leading dual-action active biologic patch.”prnewswire.com

• 1 source
• prnewswire.comEQT to acquire the TachoSil® biosurgery business from Corza MedicalEQTJul 7, 2026

Summarized from public sources; check the original articles before acting on it.